See every side of every news story
Published loading...Updated

Reminder: Rebates Have No Correlation With High Drug Prices

Summary by PCMA
Conclusions across various reports have found that rebates secured by PBMs are NOT correlated to high and increasing list prices set solely by drug companies. Instead of interfering in the private market with misguided government mandates that benefit Big Pharma, Congress should reject those policies and focus on holding drug companies accountable for their egregious pricing practices.  Despite rebates being uncorrelated with high list prices, B…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

PCMA broke the news in on Thursday, February 13, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.